DE69932182D1 - Präparationen, die virus-ähnliche partikel als immunpotentiatoren enthalten und durch die schleimhaut verabreicht werden. - Google Patents
Präparationen, die virus-ähnliche partikel als immunpotentiatoren enthalten und durch die schleimhaut verabreicht werden.Info
- Publication number
- DE69932182D1 DE69932182D1 DE69932182T DE69932182T DE69932182D1 DE 69932182 D1 DE69932182 D1 DE 69932182D1 DE 69932182 T DE69932182 T DE 69932182T DE 69932182 T DE69932182 T DE 69932182T DE 69932182 D1 DE69932182 D1 DE 69932182D1
- Authority
- DE
- Germany
- Prior art keywords
- immunotpotentiators
- schleimhaut
- delivered
- preparations containing
- containing virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU18398 | 1998-12-02 | ||
CU1998183A CU22871A1 (es) | 1998-12-02 | 1998-12-02 | Formulaciones conteniendo partículas semejantes a virus como inmunopotenciadores por vía mucosal |
PCT/CU1999/000006 WO2000032229A1 (es) | 1998-12-02 | 1999-12-01 | Formulaciones conteniendo particulas semejantes a virus como inmunopotenciadores por via mucosal |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69932182D1 true DE69932182D1 (de) | 2006-08-10 |
DE69932182T2 DE69932182T2 (de) | 2007-05-10 |
Family
ID=5459504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1999632182 Expired - Lifetime DE69932182T2 (de) | 1998-12-02 | 1999-12-01 | Präparationen, die virus-ähnliche partikel als immunpotentiatoren enthalten und durch die schleimhaut verabreicht werden. |
Country Status (13)
Country | Link |
---|---|
US (1) | US7374766B1 (de) |
EP (1) | EP1136077B1 (de) |
CN (1) | CN1191853C (de) |
AR (1) | AR021414A1 (de) |
AT (1) | ATE331528T1 (de) |
BR (1) | BR9915946B1 (de) |
CA (1) | CA2352777C (de) |
CU (1) | CU22871A1 (de) |
DE (1) | DE69932182T2 (de) |
ES (1) | ES2264273T3 (de) |
HK (1) | HK1042424B (de) |
PT (1) | PT1136077E (de) |
WO (1) | WO2000032229A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0031079D0 (en) * | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Vaccine |
CU23031A1 (es) * | 2002-01-24 | 2005-02-23 | Ct Ingenieria Genetica Biotech | Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes |
US9045727B2 (en) | 2002-05-17 | 2015-06-02 | Emory University | Virus-like particles, methods of preparation, and immunogenic compositions |
EP1569686A4 (de) * | 2002-10-17 | 2006-10-04 | Enzo Therapeutics Inc | Verabreichung von aggregierten antigenen über die schleimhaut |
CU23405A1 (es) * | 2003-10-20 | 2009-08-04 | Ct Ingenieria Genetica Biotech | Composiciones farmacéuticas para uso terapéutico |
EP1764369A1 (de) | 2005-09-16 | 2007-03-21 | Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH | Vakzine enthaltend trunkiertes HBV core protein plus Saponin-basierendes Adjuvants |
KR100836745B1 (ko) * | 2007-01-31 | 2008-06-10 | (주)두비엘 | Hbv 백신 및 그의 제조 방법 |
WO2017041083A1 (en) * | 2015-09-04 | 2017-03-09 | Inventprise, Llc | Vlp stabilized vaccine compositions |
KR20200038339A (ko) | 2015-09-10 | 2020-04-10 | 인벤트프라이즈 엘엘씨 | 다가 vlp 접합체 |
CA3017778A1 (en) | 2016-03-31 | 2017-10-05 | Centro De Ingenieria Genetica Y Biotecnologia | Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis b virus |
TWI634899B (zh) * | 2016-11-22 | 2018-09-11 | 國立臺灣大學 | 包含類b肝病毒顆粒作為佐劑的疫苗組成物 |
BR112020022784A2 (pt) * | 2018-06-05 | 2021-02-02 | Toko Yakuhin Kogyo Co., Ltd. | sistema de administração transnasal de vacina contra hepatite b |
CN111450245A (zh) * | 2020-04-29 | 2020-07-28 | 艾棣维欣(苏州)生物制药有限公司 | 一种乙型肝炎治疗疫苗及其制备方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4547368A (en) * | 1983-12-20 | 1985-10-15 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Hepatitis B core antigen vaccine made by recombinant DNA |
US4882145A (en) | 1986-12-09 | 1989-11-21 | Scripps Clinic And Research Foundation | T cell epitopes of the hepatitis B virus nucleocapsid protein |
US6319501B1 (en) * | 1990-07-19 | 2001-11-20 | Health Research, Inc. | Method of immunizing against hepatitis B virus |
US5780036A (en) * | 1991-08-26 | 1998-07-14 | The Scripps Research Institute | Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus |
WO1993003764A1 (en) * | 1991-08-26 | 1993-03-04 | Cytel Corporation | Hla-restricted hepatitis b virus ctl epitopes |
US5840303A (en) | 1991-08-26 | 1998-11-24 | The Scripps Research Foundation | Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
DE122010000015I1 (de) * | 1992-05-23 | 2010-07-08 | Glaxosmithkline Biolog Sa | Kombinierte Impfstoffe, die Hepatitis-B-Oberflächen antigen und andere Antigene enthalten |
US5618536A (en) * | 1992-09-03 | 1997-04-08 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric papillomavirus-like particles |
AU5679394A (en) * | 1992-11-25 | 1994-06-22 | International Biotechnology Laboratories, Inc. | Hepatitis b virus vaccines |
US6153201A (en) * | 1993-03-09 | 2000-11-28 | University Of Rochester | Oral immunization with papillomavirus virus-like particles |
GB9419979D0 (en) * | 1994-10-04 | 1994-11-16 | Medeva Holdings Bv | Vaccine compositions |
GB9503863D0 (en) * | 1995-02-25 | 1995-04-19 | Smithkline Beecham Biolog | Vaccine compositions |
US5962428A (en) * | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
FR2732605B1 (fr) | 1995-04-07 | 1997-05-16 | Pasteur Merieux Serums Vacc | Composition destinee a l'induction d'une reponse immunitaire mucosale |
RU2189254C2 (ru) * | 1995-06-06 | 2002-09-20 | Америкэн Хоум Продактс Корпорэйшн | Вакцины против вирусов гепатита |
US6153392A (en) | 1997-07-30 | 2000-11-28 | Bionova Corporation | Devices and methods comprising an HBcAg from hepatitis B virus |
ES2268787T3 (es) | 1997-09-05 | 2007-03-16 | Medimmune, Inc. | Metodo in vitro de desmontaje/embalaje de particulas similares a virus (vlp) de papilomavirus. |
US6436402B1 (en) | 1999-10-15 | 2002-08-20 | Merck & Co., Inc. | Process for making human papillomavirus virus-like particles with improved properties |
-
1998
- 1998-12-02 CU CU1998183A patent/CU22871A1/es unknown
-
1999
- 1999-11-26 AR ARP990106037 patent/AR021414A1/es not_active Application Discontinuation
- 1999-12-01 WO PCT/CU1999/000006 patent/WO2000032229A1/es active IP Right Grant
- 1999-12-01 ES ES99957844T patent/ES2264273T3/es not_active Expired - Lifetime
- 1999-12-01 PT PT99957844T patent/PT1136077E/pt unknown
- 1999-12-01 BR BRPI9915946-5A patent/BR9915946B1/pt not_active IP Right Cessation
- 1999-12-01 AT AT99957844T patent/ATE331528T1/de not_active IP Right Cessation
- 1999-12-01 CN CNB998151912A patent/CN1191853C/zh not_active Expired - Lifetime
- 1999-12-01 EP EP19990957844 patent/EP1136077B1/de not_active Expired - Lifetime
- 1999-12-01 CA CA 2352777 patent/CA2352777C/en not_active Expired - Fee Related
- 1999-12-01 DE DE1999632182 patent/DE69932182T2/de not_active Expired - Lifetime
- 1999-12-01 US US09/857,402 patent/US7374766B1/en not_active Expired - Fee Related
-
2002
- 2002-02-22 HK HK02101388.6A patent/HK1042424B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2352777A1 (en) | 2000-06-08 |
WO2000032229A1 (es) | 2000-06-08 |
EP1136077A1 (de) | 2001-09-26 |
CA2352777C (en) | 2009-09-08 |
CU22871A1 (es) | 2003-10-21 |
HK1042424B (zh) | 2007-05-11 |
BR9915946A (pt) | 2001-08-21 |
ATE331528T1 (de) | 2006-07-15 |
ES2264273T3 (es) | 2006-12-16 |
BR9915946B1 (pt) | 2010-12-14 |
HK1042424A1 (en) | 2002-08-16 |
CN1191853C (zh) | 2005-03-09 |
PT1136077E (pt) | 2006-10-31 |
EP1136077B1 (de) | 2006-06-28 |
US7374766B1 (en) | 2008-05-20 |
AR021414A1 (es) | 2002-07-17 |
DE69932182T2 (de) | 2007-05-10 |
CN1332637A (zh) | 2002-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68910842D1 (de) | Dispersionen aus Verbundpartikeln. | |
DE69601765T2 (de) | Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten | |
HU0500549D0 (en) | Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof | |
ATE246492T1 (de) | Mittel, die fein verteilte, kristalline budenosid-partikel enthalten | |
BR9710372B1 (pt) | composto, e, composiÇço farmacÊutica. | |
ZA995601B (en) | Water-soluble pharmaceutical composition in an ionic complex and the use thereof. | |
WO2004058837A3 (de) | Ampholytisches copolymer und dessen verwendung | |
ZA200007299B (en) | Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol. | |
ZA964710B (en) | Novel compounds, the preparation and use thereof. | |
DE69932182D1 (de) | Präparationen, die virus-ähnliche partikel als immunpotentiatoren enthalten und durch die schleimhaut verabreicht werden. | |
AP1703A (en) | Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same. | |
WO2002102586A3 (en) | Cellulose-polymer composites and methods for manufacturing same | |
IL136942A0 (en) | Polyethoxylated castor oil, compositions containing the same and processes for the preparation thereof | |
FR2671555B1 (fr) | Agent dispersant utilise dans des compositions thermodurcissables, compositions thermodurcissables le contenant et leurs applications. | |
HRP20040171A2 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
AU2002333373A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
ZA969402B (en) | Novel oligopeptides, the preparation and use thereof. | |
ITGE940104A0 (it) | Dispositivo manipolatore per la movimentazione, in particolare per l'orientamento di pezzi, utensili, o simili. | |
AU2001294240A1 (en) | 2,2-diphenylbutanamide derivatives and medicines containing the same | |
EP0665265A3 (de) | Zusammensetzungen, enthaltend Metallpartikel im Nanometergrössenbereich. | |
DE69811651D1 (de) | Enthaarungszusammensetzungen, die bereitung und die verwendung derselben | |
HK1038914A1 (en) | 2,5-Substituted benzolsulfonylureas and thioureas,methods for the production thereof, use thereof a nd pharmaceutical preparations containing the same | |
TR26907A (tr) | Yeni poliiodine bilesikleri, hazirlik prosesi ve bunlari iceren kontrast maddesi. | |
DE584365T1 (de) | Mittel zur förderung des haarwachses und dessen wiederherstellung. | |
ZA997637B (en) | Substituted cycloheptenes, their preparation and use. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |